Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches

Accounting for risk attitudes in medical decision making under uncertainty has attracted little research. A recent proposal recommended using the results of a cost-effectiveness analysis to construct a cost-effectiveness risk-aversion curve (CERAC) to inform risk-averse decision makers choosing amon...

Descripción completa

Detalles Bibliográficos
Autor principal: Elbasha, Elamin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Practical Application
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095517/
https://www.ncbi.nlm.nih.gov/pubmed/35137340
http://dx.doi.org/10.1007/s40273-021-01123-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095517/
https://www.ncbi.nlm.nih.gov/pubmed/35137340
http://dx.doi.org/10.1007/s40273-021-01123-5

Ejemplares similares